Biotech entity
All 1 tracked stories fall under one category: clinical-trial. Precisio Biotix is most often covered alongside Apollo Hospitals, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Precisio Biotix appears in 1 tracked Biotech story from July 23, 2026.
Last mentioned: Jul 23, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: clinical-trial. Precisio Biotix is most often covered alongside Apollo Hospitals, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Precisio Biotix appears in 1 tracked Biotech story from July 23, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Precisio Biotix. Shared-story counts are live from our verified record — not editorial picks.
In a bid to develop precision antimicrobials, Apollo Hospitals and Precisio Biotix are advancing lysin-based therapies in India, a country with one of the highest AMR burdens. The collaboration will include compassionate use clinical programs, potentially accelerating regulatory pathways for this new drug class.
Precisio Biotix is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
